Friday, April 29, 2011
Cell Therapeutics Inc., of Seattle, will sell approximately $16 million worth of shares of series 12 preferred stock and warrants to purchase shares of common stock in a registered offering to three of its institutional investors.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.